nodes	percent_of_prediction	percent_of_DWPC	metapath
Bisoprolol—Conjunctivitis—Epirubicin—urinary bladder cancer	0.000724	0.000724	CcSEcCtD
Bisoprolol—Hypersensitivity—Fluorouracil—urinary bladder cancer	0.000719	0.000719	CcSEcCtD
Bisoprolol—Hepatitis—Methotrexate—urinary bladder cancer	0.000714	0.000714	CcSEcCtD
Bisoprolol—Sweating—Epirubicin—urinary bladder cancer	0.000714	0.000714	CcSEcCtD
Bisoprolol—Asthenia—Gemcitabine—urinary bladder cancer	0.000712	0.000712	CcSEcCtD
Bisoprolol—Pharyngitis—Methotrexate—urinary bladder cancer	0.000709	0.000709	CcSEcCtD
Bisoprolol—Photosensitivity reaction—Doxorubicin—urinary bladder cancer	0.000705	0.000705	CcSEcCtD
Bisoprolol—Hepatobiliary disease—Epirubicin—urinary bladder cancer	0.000704	0.000704	CcSEcCtD
Bisoprolol—Weight increased—Doxorubicin—urinary bladder cancer	0.000703	0.000703	CcSEcCtD
Bisoprolol—Pruritus—Gemcitabine—urinary bladder cancer	0.000702	0.000702	CcSEcCtD
Bisoprolol—Nausea—Thiotepa—urinary bladder cancer	0.000701	0.000701	CcSEcCtD
Bisoprolol—Sinusitis—Epirubicin—urinary bladder cancer	0.000699	0.000699	CcSEcCtD
Bisoprolol—Feeling abnormal—Etoposide—urinary bladder cancer	0.000698	0.000698	CcSEcCtD
Bisoprolol—Agranulocytosis—Epirubicin—urinary bladder cancer	0.000695	0.000695	CcSEcCtD
Bisoprolol—Pneumonia—Doxorubicin—urinary bladder cancer	0.000693	0.000693	CcSEcCtD
Bisoprolol—Gastrointestinal pain—Etoposide—urinary bladder cancer	0.000693	0.000693	CcSEcCtD
Bisoprolol—Pruritus—Fluorouracil—urinary bladder cancer	0.00069	0.00069	CcSEcCtD
Bisoprolol—Drowsiness—Doxorubicin—urinary bladder cancer	0.000689	0.000689	CcSEcCtD
Bisoprolol—Visual impairment—Methotrexate—urinary bladder cancer	0.000688	0.000688	CcSEcCtD
Bisoprolol—Hypersensitivity—Cisplatin—urinary bladder cancer	0.000681	0.000681	CcSEcCtD
Bisoprolol—Bradycardia—Epirubicin—urinary bladder cancer	0.00068	0.00068	CcSEcCtD
Bisoprolol—Diarrhoea—Gemcitabine—urinary bladder cancer	0.000679	0.000679	CcSEcCtD
Bisoprolol—Urticaria—Etoposide—urinary bladder cancer	0.000673	0.000673	CcSEcCtD
Bisoprolol—Rhinitis—Epirubicin—urinary bladder cancer	0.00067	0.00067	CcSEcCtD
Bisoprolol—Abdominal pain—Etoposide—urinary bladder cancer	0.00067	0.00067	CcSEcCtD
Bisoprolol—Body temperature increased—Etoposide—urinary bladder cancer	0.00067	0.00067	CcSEcCtD
Bisoprolol—Urinary tract infection—Doxorubicin—urinary bladder cancer	0.00067	0.00067	CcSEcCtD
Bisoprolol—Conjunctivitis—Doxorubicin—urinary bladder cancer	0.00067	0.00067	CcSEcCtD
Bisoprolol—Hepatitis—Epirubicin—urinary bladder cancer	0.000668	0.000668	CcSEcCtD
Bisoprolol—Eye disorder—Methotrexate—urinary bladder cancer	0.000667	0.000667	CcSEcCtD
Bisoprolol—Diarrhoea—Fluorouracil—urinary bladder cancer	0.000667	0.000667	CcSEcCtD
Bisoprolol—Tinnitus—Methotrexate—urinary bladder cancer	0.000666	0.000666	CcSEcCtD
Bisoprolol—Hypoaesthesia—Epirubicin—urinary bladder cancer	0.000665	0.000665	CcSEcCtD
Bisoprolol—Asthenia—Cisplatin—urinary bladder cancer	0.000663	0.000663	CcSEcCtD
Bisoprolol—Pharyngitis—Epirubicin—urinary bladder cancer	0.000663	0.000663	CcSEcCtD
Bisoprolol—Cardiac disorder—Methotrexate—urinary bladder cancer	0.000663	0.000663	CcSEcCtD
Bisoprolol—Sweating—Doxorubicin—urinary bladder cancer	0.00066	0.00066	CcSEcCtD
Bisoprolol—Oedema peripheral—Epirubicin—urinary bladder cancer	0.000658	0.000658	CcSEcCtD
Bisoprolol—Connective tissue disorder—Epirubicin—urinary bladder cancer	0.000657	0.000657	CcSEcCtD
Bisoprolol—Hepatobiliary disease—Doxorubicin—urinary bladder cancer	0.000652	0.000652	CcSEcCtD
Bisoprolol—Angiopathy—Methotrexate—urinary bladder cancer	0.000648	0.000648	CcSEcCtD
Bisoprolol—Sinusitis—Doxorubicin—urinary bladder cancer	0.000646	0.000646	CcSEcCtD
Bisoprolol—Dizziness—Fluorouracil—urinary bladder cancer	0.000645	0.000645	CcSEcCtD
Bisoprolol—Visual impairment—Epirubicin—urinary bladder cancer	0.000644	0.000644	CcSEcCtD
Bisoprolol—Mediastinal disorder—Methotrexate—urinary bladder cancer	0.000644	0.000644	CcSEcCtD
Bisoprolol—Agranulocytosis—Doxorubicin—urinary bladder cancer	0.000643	0.000643	CcSEcCtD
Bisoprolol—Diarrhoea—Cisplatin—urinary bladder cancer	0.000633	0.000633	CcSEcCtD
Bisoprolol—Alopecia—Methotrexate—urinary bladder cancer	0.000631	0.000631	CcSEcCtD
Bisoprolol—Vomiting—Gemcitabine—urinary bladder cancer	0.000631	0.000631	CcSEcCtD
Bisoprolol—Bradycardia—Doxorubicin—urinary bladder cancer	0.00063	0.00063	CcSEcCtD
Bisoprolol—Mental disorder—Methotrexate—urinary bladder cancer	0.000626	0.000626	CcSEcCtD
Bisoprolol—Rash—Gemcitabine—urinary bladder cancer	0.000626	0.000626	CcSEcCtD
Bisoprolol—Dermatitis—Gemcitabine—urinary bladder cancer	0.000625	0.000625	CcSEcCtD
Bisoprolol—Eye disorder—Epirubicin—urinary bladder cancer	0.000625	0.000625	CcSEcCtD
Bisoprolol—Hypersensitivity—Etoposide—urinary bladder cancer	0.000624	0.000624	CcSEcCtD
Bisoprolol—Tinnitus—Epirubicin—urinary bladder cancer	0.000623	0.000623	CcSEcCtD
Bisoprolol—Erythema—Methotrexate—urinary bladder cancer	0.000622	0.000622	CcSEcCtD
Bisoprolol—Headache—Gemcitabine—urinary bladder cancer	0.000622	0.000622	CcSEcCtD
Bisoprolol—Flushing—Epirubicin—urinary bladder cancer	0.00062	0.00062	CcSEcCtD
Bisoprolol—Cardiac disorder—Epirubicin—urinary bladder cancer	0.00062	0.00062	CcSEcCtD
Bisoprolol—Vomiting—Fluorouracil—urinary bladder cancer	0.00062	0.00062	CcSEcCtD
Bisoprolol—Rhinitis—Doxorubicin—urinary bladder cancer	0.00062	0.00062	CcSEcCtD
Bisoprolol—Hepatitis—Doxorubicin—urinary bladder cancer	0.000618	0.000618	CcSEcCtD
Bisoprolol—Hypoaesthesia—Doxorubicin—urinary bladder cancer	0.000615	0.000615	CcSEcCtD
Bisoprolol—Rash—Fluorouracil—urinary bladder cancer	0.000615	0.000615	CcSEcCtD
Bisoprolol—Dermatitis—Fluorouracil—urinary bladder cancer	0.000614	0.000614	CcSEcCtD
Bisoprolol—Pharyngitis—Doxorubicin—urinary bladder cancer	0.000614	0.000614	CcSEcCtD
Bisoprolol—Headache—Fluorouracil—urinary bladder cancer	0.000611	0.000611	CcSEcCtD
Bisoprolol—Oedema peripheral—Doxorubicin—urinary bladder cancer	0.000609	0.000609	CcSEcCtD
Bisoprolol—Dysgeusia—Methotrexate—urinary bladder cancer	0.000609	0.000609	CcSEcCtD
Bisoprolol—Asthenia—Etoposide—urinary bladder cancer	0.000608	0.000608	CcSEcCtD
Bisoprolol—Connective tissue disorder—Doxorubicin—urinary bladder cancer	0.000608	0.000608	CcSEcCtD
Bisoprolol—Angiopathy—Epirubicin—urinary bladder cancer	0.000606	0.000606	CcSEcCtD
Bisoprolol—Mediastinal disorder—Epirubicin—urinary bladder cancer	0.000602	0.000602	CcSEcCtD
Bisoprolol—Back pain—Methotrexate—urinary bladder cancer	0.000601	0.000601	CcSEcCtD
Bisoprolol—Pruritus—Etoposide—urinary bladder cancer	0.000599	0.000599	CcSEcCtD
Bisoprolol—Arrhythmia—Epirubicin—urinary bladder cancer	0.000597	0.000597	CcSEcCtD
Bisoprolol—Visual impairment—Doxorubicin—urinary bladder cancer	0.000596	0.000596	CcSEcCtD
Bisoprolol—Alopecia—Epirubicin—urinary bladder cancer	0.000591	0.000591	CcSEcCtD
Bisoprolol—Nausea—Gemcitabine—urinary bladder cancer	0.000589	0.000589	CcSEcCtD
Bisoprolol—Vomiting—Cisplatin—urinary bladder cancer	0.000588	0.000588	CcSEcCtD
Bisoprolol—Mental disorder—Epirubicin—urinary bladder cancer	0.000586	0.000586	CcSEcCtD
Bisoprolol—Rash—Cisplatin—urinary bladder cancer	0.000583	0.000583	CcSEcCtD
Bisoprolol—Dermatitis—Cisplatin—urinary bladder cancer	0.000583	0.000583	CcSEcCtD
Bisoprolol—Erythema—Epirubicin—urinary bladder cancer	0.000582	0.000582	CcSEcCtD
Bisoprolol—Diarrhoea—Etoposide—urinary bladder cancer	0.00058	0.00058	CcSEcCtD
Bisoprolol—Nausea—Fluorouracil—urinary bladder cancer	0.000579	0.000579	CcSEcCtD
Bisoprolol—Eye disorder—Doxorubicin—urinary bladder cancer	0.000578	0.000578	CcSEcCtD
Bisoprolol—Ill-defined disorder—Methotrexate—urinary bladder cancer	0.000577	0.000577	CcSEcCtD
Bisoprolol—Tinnitus—Doxorubicin—urinary bladder cancer	0.000577	0.000577	CcSEcCtD
Bisoprolol—Cardiac disorder—Doxorubicin—urinary bladder cancer	0.000574	0.000574	CcSEcCtD
Bisoprolol—Flushing—Doxorubicin—urinary bladder cancer	0.000574	0.000574	CcSEcCtD
Bisoprolol—Dysgeusia—Epirubicin—urinary bladder cancer	0.00057	0.00057	CcSEcCtD
Bisoprolol—Back pain—Epirubicin—urinary bladder cancer	0.000563	0.000563	CcSEcCtD
Bisoprolol—Angiopathy—Doxorubicin—urinary bladder cancer	0.000561	0.000561	CcSEcCtD
Bisoprolol—Malaise—Methotrexate—urinary bladder cancer	0.000561	0.000561	CcSEcCtD
Bisoprolol—Dizziness—Etoposide—urinary bladder cancer	0.00056	0.00056	CcSEcCtD
Bisoprolol—Muscle spasms—Epirubicin—urinary bladder cancer	0.000559	0.000559	CcSEcCtD
Bisoprolol—Vertigo—Methotrexate—urinary bladder cancer	0.000559	0.000559	CcSEcCtD
Bisoprolol—Mediastinal disorder—Doxorubicin—urinary bladder cancer	0.000557	0.000557	CcSEcCtD
Bisoprolol—Arrhythmia—Doxorubicin—urinary bladder cancer	0.000553	0.000553	CcSEcCtD
Bisoprolol—Nausea—Cisplatin—urinary bladder cancer	0.000549	0.000549	CcSEcCtD
Bisoprolol—Alopecia—Doxorubicin—urinary bladder cancer	0.000547	0.000547	CcSEcCtD
Bisoprolol—Cough—Methotrexate—urinary bladder cancer	0.000543	0.000543	CcSEcCtD
Bisoprolol—Mental disorder—Doxorubicin—urinary bladder cancer	0.000542	0.000542	CcSEcCtD
Bisoprolol—Ill-defined disorder—Epirubicin—urinary bladder cancer	0.00054	0.00054	CcSEcCtD
Bisoprolol—Vomiting—Etoposide—urinary bladder cancer	0.000539	0.000539	CcSEcCtD
Bisoprolol—Erythema—Doxorubicin—urinary bladder cancer	0.000538	0.000538	CcSEcCtD
Bisoprolol—Agitation—Epirubicin—urinary bladder cancer	0.000535	0.000535	CcSEcCtD
Bisoprolol—Rash—Etoposide—urinary bladder cancer	0.000534	0.000534	CcSEcCtD
Bisoprolol—Dermatitis—Etoposide—urinary bladder cancer	0.000534	0.000534	CcSEcCtD
Bisoprolol—Headache—Etoposide—urinary bladder cancer	0.000531	0.000531	CcSEcCtD
Bisoprolol—Chest pain—Methotrexate—urinary bladder cancer	0.000529	0.000529	CcSEcCtD
Bisoprolol—Myalgia—Methotrexate—urinary bladder cancer	0.000529	0.000529	CcSEcCtD
Bisoprolol—Arthralgia—Methotrexate—urinary bladder cancer	0.000529	0.000529	CcSEcCtD
Bisoprolol—Dysgeusia—Doxorubicin—urinary bladder cancer	0.000527	0.000527	CcSEcCtD
Bisoprolol—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—urinary bladder cancer	0.000526	0.000526	CcSEcCtD
Bisoprolol—Malaise—Epirubicin—urinary bladder cancer	0.000525	0.000525	CcSEcCtD
Bisoprolol—Discomfort—Methotrexate—urinary bladder cancer	0.000523	0.000523	CcSEcCtD
Bisoprolol—Vertigo—Epirubicin—urinary bladder cancer	0.000523	0.000523	CcSEcCtD
Bisoprolol—Syncope—Epirubicin—urinary bladder cancer	0.000522	0.000522	CcSEcCtD
Bisoprolol—Back pain—Doxorubicin—urinary bladder cancer	0.000521	0.000521	CcSEcCtD
Bisoprolol—Muscle spasms—Doxorubicin—urinary bladder cancer	0.000518	0.000518	CcSEcCtD
Bisoprolol—Palpitations—Epirubicin—urinary bladder cancer	0.000514	0.000514	CcSEcCtD
Bisoprolol—Confusional state—Methotrexate—urinary bladder cancer	0.000512	0.000512	CcSEcCtD
Bisoprolol—Loss of consciousness—Epirubicin—urinary bladder cancer	0.000511	0.000511	CcSEcCtD
Bisoprolol—Cough—Epirubicin—urinary bladder cancer	0.000508	0.000508	CcSEcCtD
Bisoprolol—Infection—Methotrexate—urinary bladder cancer	0.000504	0.000504	CcSEcCtD
Bisoprolol—Nausea—Etoposide—urinary bladder cancer	0.000503	0.000503	CcSEcCtD
Bisoprolol—Ill-defined disorder—Doxorubicin—urinary bladder cancer	0.0005	0.0005	CcSEcCtD
Bisoprolol—Nervous system disorder—Methotrexate—urinary bladder cancer	0.000498	0.000498	CcSEcCtD
Bisoprolol—Thrombocytopenia—Methotrexate—urinary bladder cancer	0.000497	0.000497	CcSEcCtD
Bisoprolol—Arthralgia—Epirubicin—urinary bladder cancer	0.000495	0.000495	CcSEcCtD
Bisoprolol—Chest pain—Epirubicin—urinary bladder cancer	0.000495	0.000495	CcSEcCtD
Bisoprolol—Myalgia—Epirubicin—urinary bladder cancer	0.000495	0.000495	CcSEcCtD
Bisoprolol—Agitation—Doxorubicin—urinary bladder cancer	0.000495	0.000495	CcSEcCtD
Bisoprolol—Anxiety—Epirubicin—urinary bladder cancer	0.000494	0.000494	CcSEcCtD
Bisoprolol—Skin disorder—Methotrexate—urinary bladder cancer	0.000493	0.000493	CcSEcCtD
Bisoprolol—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—urinary bladder cancer	0.000492	0.000492	CcSEcCtD
Bisoprolol—Hyperhidrosis—Methotrexate—urinary bladder cancer	0.000491	0.000491	CcSEcCtD
Bisoprolol—Discomfort—Epirubicin—urinary bladder cancer	0.000489	0.000489	CcSEcCtD
Bisoprolol—Malaise—Doxorubicin—urinary bladder cancer	0.000486	0.000486	CcSEcCtD
Bisoprolol—Dry mouth—Epirubicin—urinary bladder cancer	0.000484	0.000484	CcSEcCtD
Bisoprolol—Vertigo—Doxorubicin—urinary bladder cancer	0.000484	0.000484	CcSEcCtD
Bisoprolol—Syncope—Doxorubicin—urinary bladder cancer	0.000483	0.000483	CcSEcCtD
Bisoprolol—Confusional state—Epirubicin—urinary bladder cancer	0.000479	0.000479	CcSEcCtD
Bisoprolol—Palpitations—Doxorubicin—urinary bladder cancer	0.000476	0.000476	CcSEcCtD
Bisoprolol—Oedema—Epirubicin—urinary bladder cancer	0.000475	0.000475	CcSEcCtD
Bisoprolol—Hypotension—Methotrexate—urinary bladder cancer	0.000474	0.000474	CcSEcCtD
Bisoprolol—Loss of consciousness—Doxorubicin—urinary bladder cancer	0.000473	0.000473	CcSEcCtD
Bisoprolol—Infection—Epirubicin—urinary bladder cancer	0.000472	0.000472	CcSEcCtD
Bisoprolol—Cough—Doxorubicin—urinary bladder cancer	0.00047	0.00047	CcSEcCtD
Bisoprolol—Shock—Epirubicin—urinary bladder cancer	0.000467	0.000467	CcSEcCtD
Bisoprolol—Nervous system disorder—Epirubicin—urinary bladder cancer	0.000466	0.000466	CcSEcCtD
Bisoprolol—Thrombocytopenia—Epirubicin—urinary bladder cancer	0.000465	0.000465	CcSEcCtD
Bisoprolol—Tachycardia—Epirubicin—urinary bladder cancer	0.000463	0.000463	CcSEcCtD
Bisoprolol—Musculoskeletal discomfort—Methotrexate—urinary bladder cancer	0.000462	0.000462	CcSEcCtD
Bisoprolol—Skin disorder—Epirubicin—urinary bladder cancer	0.000461	0.000461	CcSEcCtD
Bisoprolol—Hyperhidrosis—Epirubicin—urinary bladder cancer	0.000459	0.000459	CcSEcCtD
Bisoprolol—Insomnia—Methotrexate—urinary bladder cancer	0.000459	0.000459	CcSEcCtD
Bisoprolol—Chest pain—Doxorubicin—urinary bladder cancer	0.000458	0.000458	CcSEcCtD
Bisoprolol—Arthralgia—Doxorubicin—urinary bladder cancer	0.000458	0.000458	CcSEcCtD
Bisoprolol—Myalgia—Doxorubicin—urinary bladder cancer	0.000458	0.000458	CcSEcCtD
Bisoprolol—Anxiety—Doxorubicin—urinary bladder cancer	0.000457	0.000457	CcSEcCtD
Bisoprolol—Paraesthesia—Methotrexate—urinary bladder cancer	0.000456	0.000456	CcSEcCtD
Bisoprolol—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—urinary bladder cancer	0.000455	0.000455	CcSEcCtD
Bisoprolol—Discomfort—Doxorubicin—urinary bladder cancer	0.000453	0.000453	CcSEcCtD
Bisoprolol—Dyspnoea—Methotrexate—urinary bladder cancer	0.000452	0.000452	CcSEcCtD
Bisoprolol—Somnolence—Methotrexate—urinary bladder cancer	0.000451	0.000451	CcSEcCtD
Bisoprolol—Dry mouth—Doxorubicin—urinary bladder cancer	0.000448	0.000448	CcSEcCtD
Bisoprolol—Dyspepsia—Methotrexate—urinary bladder cancer	0.000447	0.000447	CcSEcCtD
Bisoprolol—Hypotension—Epirubicin—urinary bladder cancer	0.000444	0.000444	CcSEcCtD
Bisoprolol—Confusional state—Doxorubicin—urinary bladder cancer	0.000443	0.000443	CcSEcCtD
Bisoprolol—Oedema—Doxorubicin—urinary bladder cancer	0.000439	0.000439	CcSEcCtD
Bisoprolol—Gastrointestinal disorder—Methotrexate—urinary bladder cancer	0.000438	0.000438	CcSEcCtD
Bisoprolol—Fatigue—Methotrexate—urinary bladder cancer	0.000437	0.000437	CcSEcCtD
Bisoprolol—Infection—Doxorubicin—urinary bladder cancer	0.000437	0.000437	CcSEcCtD
Bisoprolol—Pain—Methotrexate—urinary bladder cancer	0.000434	0.000434	CcSEcCtD
Bisoprolol—Musculoskeletal discomfort—Epirubicin—urinary bladder cancer	0.000433	0.000433	CcSEcCtD
Bisoprolol—Shock—Doxorubicin—urinary bladder cancer	0.000432	0.000432	CcSEcCtD
Bisoprolol—Nervous system disorder—Doxorubicin—urinary bladder cancer	0.000431	0.000431	CcSEcCtD
Bisoprolol—Thrombocytopenia—Doxorubicin—urinary bladder cancer	0.00043	0.00043	CcSEcCtD
Bisoprolol—Insomnia—Epirubicin—urinary bladder cancer	0.00043	0.00043	CcSEcCtD
Bisoprolol—Tachycardia—Doxorubicin—urinary bladder cancer	0.000429	0.000429	CcSEcCtD
Bisoprolol—Skin disorder—Doxorubicin—urinary bladder cancer	0.000427	0.000427	CcSEcCtD
Bisoprolol—Paraesthesia—Epirubicin—urinary bladder cancer	0.000426	0.000426	CcSEcCtD
Bisoprolol—Hyperhidrosis—Doxorubicin—urinary bladder cancer	0.000425	0.000425	CcSEcCtD
Bisoprolol—Dyspnoea—Epirubicin—urinary bladder cancer	0.000423	0.000423	CcSEcCtD
Bisoprolol—Somnolence—Epirubicin—urinary bladder cancer	0.000422	0.000422	CcSEcCtD
Bisoprolol—Feeling abnormal—Methotrexate—urinary bladder cancer	0.000418	0.000418	CcSEcCtD
Bisoprolol—Dyspepsia—Epirubicin—urinary bladder cancer	0.000418	0.000418	CcSEcCtD
Bisoprolol—Gastrointestinal pain—Methotrexate—urinary bladder cancer	0.000415	0.000415	CcSEcCtD
Bisoprolol—Hypotension—Doxorubicin—urinary bladder cancer	0.000411	0.000411	CcSEcCtD
Bisoprolol—Gastrointestinal disorder—Epirubicin—urinary bladder cancer	0.00041	0.00041	CcSEcCtD
Bisoprolol—Fatigue—Epirubicin—urinary bladder cancer	0.000409	0.000409	CcSEcCtD
Bisoprolol—Constipation—Epirubicin—urinary bladder cancer	0.000406	0.000406	CcSEcCtD
Bisoprolol—Pain—Epirubicin—urinary bladder cancer	0.000406	0.000406	CcSEcCtD
Bisoprolol—Urticaria—Methotrexate—urinary bladder cancer	0.000403	0.000403	CcSEcCtD
Bisoprolol—Body temperature increased—Methotrexate—urinary bladder cancer	0.000401	0.000401	CcSEcCtD
Bisoprolol—Abdominal pain—Methotrexate—urinary bladder cancer	0.000401	0.000401	CcSEcCtD
Bisoprolol—Musculoskeletal discomfort—Doxorubicin—urinary bladder cancer	0.0004	0.0004	CcSEcCtD
Bisoprolol—Insomnia—Doxorubicin—urinary bladder cancer	0.000397	0.000397	CcSEcCtD
Bisoprolol—Paraesthesia—Doxorubicin—urinary bladder cancer	0.000395	0.000395	CcSEcCtD
Bisoprolol—Dyspnoea—Doxorubicin—urinary bladder cancer	0.000392	0.000392	CcSEcCtD
Bisoprolol—Feeling abnormal—Epirubicin—urinary bladder cancer	0.000391	0.000391	CcSEcCtD
Bisoprolol—Somnolence—Doxorubicin—urinary bladder cancer	0.000391	0.000391	CcSEcCtD
Bisoprolol—Gastrointestinal pain—Epirubicin—urinary bladder cancer	0.000388	0.000388	CcSEcCtD
Bisoprolol—Dyspepsia—Doxorubicin—urinary bladder cancer	0.000387	0.000387	CcSEcCtD
Bisoprolol—Gastrointestinal disorder—Doxorubicin—urinary bladder cancer	0.000379	0.000379	CcSEcCtD
Bisoprolol—Fatigue—Doxorubicin—urinary bladder cancer	0.000379	0.000379	CcSEcCtD
Bisoprolol—Urticaria—Epirubicin—urinary bladder cancer	0.000377	0.000377	CcSEcCtD
Bisoprolol—Pain—Doxorubicin—urinary bladder cancer	0.000376	0.000376	CcSEcCtD
Bisoprolol—Constipation—Doxorubicin—urinary bladder cancer	0.000376	0.000376	CcSEcCtD
Bisoprolol—Abdominal pain—Epirubicin—urinary bladder cancer	0.000375	0.000375	CcSEcCtD
Bisoprolol—Body temperature increased—Epirubicin—urinary bladder cancer	0.000375	0.000375	CcSEcCtD
Bisoprolol—Hypersensitivity—Methotrexate—urinary bladder cancer	0.000374	0.000374	CcSEcCtD
Bisoprolol—Asthenia—Methotrexate—urinary bladder cancer	0.000364	0.000364	CcSEcCtD
Bisoprolol—Feeling abnormal—Doxorubicin—urinary bladder cancer	0.000362	0.000362	CcSEcCtD
Bisoprolol—Gastrointestinal pain—Doxorubicin—urinary bladder cancer	0.000359	0.000359	CcSEcCtD
Bisoprolol—Pruritus—Methotrexate—urinary bladder cancer	0.000359	0.000359	CcSEcCtD
Bisoprolol—Hypersensitivity—Epirubicin—urinary bladder cancer	0.00035	0.00035	CcSEcCtD
Bisoprolol—Urticaria—Doxorubicin—urinary bladder cancer	0.000349	0.000349	CcSEcCtD
Bisoprolol—Abdominal pain—Doxorubicin—urinary bladder cancer	0.000347	0.000347	CcSEcCtD
Bisoprolol—Body temperature increased—Doxorubicin—urinary bladder cancer	0.000347	0.000347	CcSEcCtD
Bisoprolol—Diarrhoea—Methotrexate—urinary bladder cancer	0.000347	0.000347	CcSEcCtD
Bisoprolol—Asthenia—Epirubicin—urinary bladder cancer	0.000341	0.000341	CcSEcCtD
Bisoprolol—Pruritus—Epirubicin—urinary bladder cancer	0.000336	0.000336	CcSEcCtD
Bisoprolol—Dizziness—Methotrexate—urinary bladder cancer	0.000336	0.000336	CcSEcCtD
Bisoprolol—Diarrhoea—Epirubicin—urinary bladder cancer	0.000325	0.000325	CcSEcCtD
Bisoprolol—Hypersensitivity—Doxorubicin—urinary bladder cancer	0.000324	0.000324	CcSEcCtD
Bisoprolol—Vomiting—Methotrexate—urinary bladder cancer	0.000323	0.000323	CcSEcCtD
Bisoprolol—Rash—Methotrexate—urinary bladder cancer	0.00032	0.00032	CcSEcCtD
Bisoprolol—Dermatitis—Methotrexate—urinary bladder cancer	0.00032	0.00032	CcSEcCtD
Bisoprolol—Headache—Methotrexate—urinary bladder cancer	0.000318	0.000318	CcSEcCtD
Bisoprolol—Asthenia—Doxorubicin—urinary bladder cancer	0.000315	0.000315	CcSEcCtD
Bisoprolol—Dizziness—Epirubicin—urinary bladder cancer	0.000314	0.000314	CcSEcCtD
Bisoprolol—Pruritus—Doxorubicin—urinary bladder cancer	0.000311	0.000311	CcSEcCtD
Bisoprolol—Vomiting—Epirubicin—urinary bladder cancer	0.000302	0.000302	CcSEcCtD
Bisoprolol—Nausea—Methotrexate—urinary bladder cancer	0.000301	0.000301	CcSEcCtD
Bisoprolol—Diarrhoea—Doxorubicin—urinary bladder cancer	0.000301	0.000301	CcSEcCtD
Bisoprolol—Rash—Epirubicin—urinary bladder cancer	0.000299	0.000299	CcSEcCtD
Bisoprolol—Dermatitis—Epirubicin—urinary bladder cancer	0.000299	0.000299	CcSEcCtD
Bisoprolol—Headache—Epirubicin—urinary bladder cancer	0.000298	0.000298	CcSEcCtD
Bisoprolol—Dizziness—Doxorubicin—urinary bladder cancer	0.000291	0.000291	CcSEcCtD
Bisoprolol—Nausea—Epirubicin—urinary bladder cancer	0.000282	0.000282	CcSEcCtD
Bisoprolol—Vomiting—Doxorubicin—urinary bladder cancer	0.000279	0.000279	CcSEcCtD
Bisoprolol—Rash—Doxorubicin—urinary bladder cancer	0.000277	0.000277	CcSEcCtD
Bisoprolol—Dermatitis—Doxorubicin—urinary bladder cancer	0.000277	0.000277	CcSEcCtD
Bisoprolol—Headache—Doxorubicin—urinary bladder cancer	0.000275	0.000275	CcSEcCtD
Bisoprolol—Nausea—Doxorubicin—urinary bladder cancer	0.000261	0.000261	CcSEcCtD
